$500 Obamacare Rebates Are Legally Precarious. And Do Nothing for Healthcare Costs.

The Trump administration’s announcement that it will send $500 “rebate” checks to roughly 1 million Affordable Care Act (ACA) enrollees in 30 states ($500 million total) fits a familiar pattern: seeking political advantage through direct cash disbursements. Just as with President Trump’s recent proposal of $5,000 “dividend” checks if Republicans maintain control of Congress in the upcoming midterm elections, the promise of $500 health refunds position short-term consumer payouts as a quick fix for underlying affordability crises.

The White House claims the Biden administration overcharged consumers through excessive federal exchange user fees passed on in the form of higher premiums, building up an operational surplus that the president now intends to return directly to policyholders. Yet, beneath the political theater lies a stark fiscal and legal reality: disbursing these checks unilaterally without congressional authorization would almost certainly be unlawful, and would do nothing to solve the structural crisis of skyrocketing healthcare costs.

Under the separation of powers, Article I of the Constitution vests sole control over federal spending in Congress. Congress enforces this constitutional boundary through the Antideficiency Act, which makes it a criminal offense for executive officials to spend or obligate federal funds before Congress has explicitly appropriated them.

When Congress created the ACA marketplace, it authorized user fees (charged to health insurance companies selling plans on the marketplace) for a singular purpose: to fund the operations of HealthCare.gov, such as call centers and enrollment technology. The administration’s claim that it can redirect operational surpluses into $500 consumer checks has no statutory basis.

If the government collects more user fees than it needs to run the exchange, the executive branch has only two lawful choices: lower future fee rates on insurers or return the excess funds to the Treasury. It cannot manufacture a direct cash-rebate program on its own authority. By sending these checks without an act of Congress, the administration would be bypassing the basic constitutional rule that Congress holds the power of the purse.

Setting aside its legal defects, a one-time $500 refund does almost nothing to tackle the healthcare affordability crisis. First, the reach of the proposal is remarkably narrow, targeting roughly 1 million unsubsidized enrollees while ignoring the vast majority of the estimated 20 million Americans who rely on ACA marketplaces. The president doesn’t even purport to alleviate the burden on Americans who are uninsured or under-insured.

Moreover, $500 does very little to offset the sharp rise in the annual cost of coverage. When Congress allowed enhanced federal premium subsidies to expire, many policyholders faced premium spikes of hundreds to thousands of dollars per year. A $500 check does not lower the cost of health insurance; it simply shifts public funds to a relatively few consumers while leaving the root drivers of healthcare inflation completely untouched.

If the goal were genuinely to lower costs and broaden access for patients, policymakers would focus on real structural reforms rather than temporary cash relief.

First, tackling high hospital prices requires addressing the unchecked charges that drive inflation across commercial markets. While peer nations directly regulate or cap what hospitals can charge for medical services, the U.S. allows provider networks to set prices with limited oversight. In particular, as hospital systems acquire independent physician practices, they routinely tack extra, inflated “facility fees” onto routine outpatient visits — charging significantly more for the exact same care simply because of who owns the building. Banning these arbitrary add-on fees through site-neutral payment rules would bring U.S. outpatient pricing closer to international norms and directly lower expenses for consumers and insurers alike.

Second, reining in prescription drug costs could be achieved by expanding the Medicare Drug Price Negotiation Program. Currently, the federal government negotiates lower prices for a select group of high-cost medications for Medicare beneficiaries. Congress could broaden this authority to cover more drugs sooner and extend those lower, negotiated rates directly to private commercial plans, including ACA marketplaces. Pair that with out-of-pocket spending caps for essential daily drugs like insulin and inhalers, and patients with many chronic conditions would no longer be forced to skip life-saving doses.

Finally, reducing administrative overhead targets the billions of dollars wasted on insurance red tape. Standardizing and streamlining prior authorization rules would eliminate endless paperwork hurdles that delay necessary treatments, therefore lowering operational expenses and allowing clinical staff to spend their time managing patient care rather than battling health plan denials.

A single $500 payment might make for an appealing headline, but it offers only a fleeting political fix. Meaningful affordability requires tackling what healthcare actually costs — not sending unauthorized checks to paper over the bill.